| GO:0044391 | ribosomal subunit | 77.94% (53/68) | 6.27 | 0.0 | 0.0 |
| GO:0003735 | structural constituent of ribosome | 77.94% (53/68) | 6.23 | 0.0 | 0.0 |
| GO:0005198 | structural molecule activity | 79.41% (54/68) | 5.73 | 0.0 | 0.0 |
| GO:1990904 | ribonucleoprotein complex | 85.29% (58/68) | 4.9 | 0.0 | 0.0 |
| GO:0006412 | translation | 70.59% (48/68) | 5.89 | 0.0 | 0.0 |
| GO:0002181 | cytoplasmic translation | 61.76% (42/68) | 6.62 | 0.0 | 0.0 |
| GO:0043043 | peptide biosynthetic process | 70.59% (48/68) | 5.81 | 0.0 | 0.0 |
| GO:0043604 | amide biosynthetic process | 70.59% (48/68) | 5.38 | 0.0 | 0.0 |
| GO:0006518 | peptide metabolic process | 70.59% (48/68) | 5.31 | 0.0 | 0.0 |
| GO:0034645 | cellular macromolecule biosynthetic process | 75.0% (51/68) | 4.96 | 0.0 | 0.0 |
| GO:0022625 | cytosolic large ribosomal subunit | 52.94% (36/68) | 6.67 | 0.0 | 0.0 |
| GO:0009059 | macromolecule biosynthetic process | 79.41% (54/68) | 4.34 | 0.0 | 0.0 |
| GO:0015934 | large ribosomal subunit | 52.94% (36/68) | 6.42 | 0.0 | 0.0 |
| GO:0043603 | cellular amide metabolic process | 70.59% (48/68) | 4.71 | 0.0 | 0.0 |
| GO:0044271 | cellular nitrogen compound biosynthetic process | 76.47% (52/68) | 3.94 | 0.0 | 0.0 |
| GO:0003723 | RNA binding | 80.88% (55/68) | 3.64 | 0.0 | 0.0 |
| GO:0042788 | polysomal ribosome | 45.59% (31/68) | 6.26 | 0.0 | 0.0 |
| GO:0003729 | mRNA binding | 70.59% (48/68) | 4.05 | 0.0 | 0.0 |
| GO:0032991 | protein-containing complex | 91.18% (62/68) | 2.88 | 0.0 | 0.0 |
| GO:0044260 | cellular macromolecule metabolic process | 82.35% (56/68) | 3.23 | 0.0 | 0.0 |
| GO:1901566 | organonitrogen compound biosynthetic process | 72.06% (49/68) | 3.64 | 0.0 | 0.0 |
| GO:0005840 | ribosome | 45.59% (31/68) | 5.25 | 0.0 | 0.0 |
| GO:0043228 | non-membrane-bounded organelle | 75.0% (51/68) | 3.09 | 0.0 | 0.0 |
| GO:0043232 | intracellular non-membrane-bounded organelle | 75.0% (51/68) | 3.09 | 0.0 | 0.0 |
| GO:0005730 | nucleolus | 55.88% (38/68) | 4.01 | 0.0 | 0.0 |
| GO:0034641 | cellular nitrogen compound metabolic process | 80.88% (55/68) | 2.57 | 0.0 | 0.0 |
| GO:0044249 | cellular biosynthetic process | 80.88% (55/68) | 2.53 | 0.0 | 0.0 |
| GO:0003676 | nucleic acid binding | 80.88% (55/68) | 2.48 | 0.0 | 0.0 |
| GO:1901576 | organic substance biosynthetic process | 80.88% (55/68) | 2.44 | 0.0 | 0.0 |
| GO:0019538 | protein metabolic process | 77.94% (53/68) | 2.53 | 0.0 | 0.0 |
| GO:0009058 | biosynthetic process | 80.88% (55/68) | 2.37 | 0.0 | 0.0 |
| GO:0015935 | small ribosomal subunit | 29.41% (20/68) | 6.14 | 0.0 | 0.0 |
| GO:0022627 | cytosolic small ribosomal subunit | 27.94% (19/68) | 6.29 | 0.0 | 0.0 |
| GO:0043170 | macromolecule metabolic process | 85.29% (58/68) | 1.93 | 0.0 | 0.0 |
| GO:0098556 | cytoplasmic side of rough endoplasmic reticulum membrane | 22.06% (15/68) | 6.65 | 0.0 | 0.0 |
| GO:0019843 | rRNA binding | 27.94% (19/68) | 5.48 | 0.0 | 0.0 |
| GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane | 22.06% (15/68) | 6.61 | 0.0 | 0.0 |
| GO:1901363 | heterocyclic compound binding | 82.35% (56/68) | 1.73 | 0.0 | 0.0 |
| GO:0097159 | organic cyclic compound binding | 82.35% (56/68) | 1.72 | 0.0 | 0.0 |
| GO:1901564 | organonitrogen compound metabolic process | 77.94% (53/68) | 1.84 | 0.0 | 0.0 |
| GO:0098562 | cytoplasmic side of membrane | 22.06% (15/68) | 5.74 | 0.0 | 0.0 |
| GO:0006807 | nitrogen compound metabolic process | 83.82% (57/68) | 1.59 | 0.0 | 0.0 |
| GO:0006364 | rRNA processing | 26.47% (18/68) | 4.64 | 0.0 | 0.0 |
| GO:0016072 | rRNA metabolic process | 26.47% (18/68) | 4.5 | 0.0 | 0.0 |
| GO:0044238 | primary metabolic process | 85.29% (58/68) | 1.42 | 0.0 | 0.0 |
| GO:0044237 | cellular metabolic process | 86.76% (59/68) | 1.36 | 0.0 | 0.0 |
| GO:0098552 | side of membrane | 22.06% (15/68) | 4.96 | 0.0 | 0.0 |
| GO:0014069 | postsynaptic density | 19.12% (13/68) | 5.41 | 0.0 | 0.0 |
| GO:0099572 | postsynaptic specialization | 19.12% (13/68) | 5.41 | 0.0 | 0.0 |
| GO:0071704 | organic substance metabolic process | 86.76% (59/68) | 1.23 | 0.0 | 0.0 |
| GO:0031100 | animal organ regeneration | 14.71% (10/68) | 6.17 | 0.0 | 0.0 |
| GO:0034470 | ncRNA processing | 27.94% (19/68) | 3.64 | 0.0 | 0.0 |
| GO:0097421 | liver regeneration | 13.24% (9/68) | 6.53 | 0.0 | 0.0 |
| GO:0030054 | cell junction | 47.06% (32/68) | 2.34 | 0.0 | 0.0 |
| GO:0045202 | synapse | 23.53% (16/68) | 4.12 | 0.0 | 0.0 |
| GO:0008152 | metabolic process | 86.76% (59/68) | 1.13 | 0.0 | 0.0 |
| GO:0034660 | ncRNA metabolic process | 27.94% (19/68) | 3.36 | 0.0 | 0.0 |
| GO:0006417 | regulation of translation | 22.06% (15/68) | 3.78 | 0.0 | 0.0 |
| GO:0005488 | binding | 91.18% (62/68) | 0.86 | 0.0 | 0.0 |
| GO:0034248 | regulation of cellular amide metabolic process | 22.06% (15/68) | 3.69 | 0.0 | 0.0 |
| GO:0022618 | ribonucleoprotein complex assembly | 17.65% (12/68) | 4.36 | 0.0 | 0.0 |
| GO:0031099 | regeneration | 14.71% (10/68) | 5.0 | 0.0 | 0.0 |
| GO:2000112 | regulation of cellular macromolecule biosynthetic process | 23.53% (16/68) | 3.46 | 0.0 | 0.0 |
| GO:0071826 | ribonucleoprotein complex subunit organization | 17.65% (12/68) | 4.28 | 0.0 | 0.0 |
| GO:0005654 | nucleoplasm | 30.88% (21/68) | 2.76 | 0.0 | 0.0 |
| GO:0001889 | liver development | 13.24% (9/68) | 5.29 | 0.0 | 0.0 |
| GO:0048513 | animal organ development | 25.0% (17/68) | 3.14 | 0.0 | 0.0 |
| GO:0006396 | RNA processing | 29.41% (20/68) | 2.77 | 0.0 | 0.0 |
| GO:0045727 | positive regulation of translation | 14.71% (10/68) | 4.66 | 0.0 | 0.0 |
| GO:0010608 | post-transcriptional regulation of gene expression | 22.06% (15/68) | 3.38 | 0.0 | 0.0 |
| GO:0034250 | positive regulation of cellular amide metabolic process | 14.71% (10/68) | 4.48 | 0.0 | 0.0 |
| GO:0016070 | RNA metabolic process | 32.35% (22/68) | 2.44 | 0.0 | 0.0 |
| GO:0043229 | intracellular organelle | 79.41% (54/68) | 0.99 | 0.0 | 0.0 |
| GO:0043226 | organelle | 79.41% (54/68) | 0.98 | 0.0 | 0.0 |
| GO:0051246 | regulation of protein metabolic process | 30.88% (21/68) | 2.48 | 0.0 | 0.0 |
| GO:0043009 | chordate embryonic development | 13.24% (9/68) | 4.72 | 0.0 | 0.0 |
| GO:0009955 | adaxial/abaxial pattern specification | 7.35% (5/68) | 7.4 | 0.0 | 0.0 |
| GO:0048732 | gland development | 13.24% (9/68) | 4.68 | 0.0 | 0.0 |
| GO:0005732 | sno(s)RNA-containing ribonucleoprotein complex | 8.82% (6/68) | 6.39 | 0.0 | 0.0 |
| GO:0003674 | molecular_function | 94.12% (64/68) | 0.66 | 0.0 | 0.0 |
| GO:0005886 | plasma membrane | 45.59% (31/68) | 1.74 | 0.0 | 0.0 |
| GO:0009792 | embryo development ending in birth or egg hatching | 14.71% (10/68) | 4.19 | 0.0 | 0.0 |
| GO:0009987 | cellular process | 88.24% (60/68) | 0.76 | 0.0 | 0.0 |
| GO:0061844 | antimicrobial humoral immune response mediated by antimicrobial peptide | 5.88% (4/68) | 8.36 | 0.0 | 0.0 |
| GO:0005575 | cellular_component | 94.12% (64/68) | 0.62 | 0.0 | 0.0 |
| GO:0090304 | nucleic acid metabolic process | 35.29% (24/68) | 2.1 | 0.0 | 0.0 |
| GO:0010628 | positive regulation of gene expression | 20.59% (14/68) | 3.13 | 0.0 | 0.0 |
| GO:0008150 | biological_process | 94.12% (64/68) | 0.61 | 0.0 | 0.0 |
| GO:0031672 | A band | 7.35% (5/68) | 6.58 | 0.0 | 0.0 |
| GO:0005515 | protein binding | 73.53% (50/68) | 0.96 | 0.0 | 0.0 |
| GO:0019730 | antimicrobial humoral response | 5.88% (4/68) | 7.71 | 0.0 | 0.0 |
| GO:0051247 | positive regulation of protein metabolic process | 20.59% (14/68) | 2.92 | 0.0 | 0.0 |
| GO:0005774 | vacuolar membrane | 26.47% (18/68) | 2.42 | 0.0 | 0.0 |
| GO:0006139 | nucleobase-containing compound metabolic process | 36.76% (25/68) | 1.86 | 0.0 | 0.0 |
| GO:0070180 | large ribosomal subunit rRNA binding | 7.35% (5/68) | 6.36 | 0.0 | 0.0 |
| GO:0098588 | bounding membrane of organelle | 32.35% (22/68) | 2.05 | 0.0 | 0.0 |
| GO:1904571 | positive regulation of selenocysteine incorporation | 4.41% (3/68) | 9.17 | 0.0 | 0.0 |
| GO:0030684 | preribosome | 10.29% (7/68) | 4.76 | 0.0 | 0.0 |
| GO:0005618 | cell wall | 25.0% (17/68) | 2.42 | 0.0 | 0.0 |
| GO:1904569 | regulation of selenocysteine incorporation | 4.41% (3/68) | 8.75 | 0.0 | 0.0 |
| GO:0030312 | external encapsulating structure | 25.0% (17/68) | 2.33 | 0.0 | 0.0 |
| GO:0000027 | ribosomal large subunit assembly | 7.35% (5/68) | 5.79 | 0.0 | 1e-06 |
| GO:0030687 | preribosome, large subunit precursor | 7.35% (5/68) | 5.66 | 0.0 | 1e-06 |
| GO:0110165 | cellular anatomical entity | 89.71% (61/68) | 0.58 | 0.0 | 1e-06 |
| GO:0000470 | maturation of LSU-rRNA | 7.35% (5/68) | 5.49 | 0.0 | 1e-06 |
| GO:0035368 | selenocysteine insertion sequence binding | 4.41% (3/68) | 8.17 | 0.0 | 1e-06 |
| GO:0009506 | plasmodesma | 29.41% (20/68) | 1.91 | 0.0 | 2e-06 |
| GO:0005911 | cell-cell junction | 29.41% (20/68) | 1.88 | 0.0 | 3e-06 |
| GO:0031369 | translation initiation factor binding | 7.35% (5/68) | 5.26 | 0.0 | 3e-06 |
| GO:0070161 | anchoring junction | 29.41% (20/68) | 1.87 | 0.0 | 3e-06 |
| GO:1990928 | response to amino acid starvation | 5.88% (4/68) | 6.21 | 0.0 | 4e-06 |
| GO:0008097 | 5S rRNA binding | 5.88% (4/68) | 6.12 | 0.0 | 5e-06 |
| GO:0080090 | regulation of primary metabolic process | 41.18% (28/68) | 1.41 | 0.0 | 5e-06 |
| GO:0050794 | regulation of cellular process | 58.82% (40/68) | 1.01 | 0.0 | 5e-06 |
| GO:0006959 | humoral immune response | 5.88% (4/68) | 6.08 | 0.0 | 5e-06 |
| GO:0051726 | regulation of cell cycle | 17.65% (12/68) | 2.65 | 0.0 | 5e-06 |
| GO:0022613 | ribonucleoprotein complex biogenesis | 8.82% (6/68) | 4.41 | 0.0 | 5e-06 |
| GO:0043933 | protein-containing complex organization | 20.59% (14/68) | 2.36 | 0.0 | 5e-06 |
| GO:0000028 | ribosomal small subunit assembly | 5.88% (4/68) | 6.0 | 0.0 | 6e-06 |
| GO:0060255 | regulation of macromolecule metabolic process | 41.18% (28/68) | 1.38 | 0.0 | 6e-06 |
| GO:0007420 | brain development | 8.82% (6/68) | 4.34 | 1e-06 | 7e-06 |
| GO:0046483 | heterocycle metabolic process | 36.76% (25/68) | 1.48 | 1e-06 | 1e-05 |
| GO:1901798 | positive regulation of signal transduction by p53 class mediator | 5.88% (4/68) | 5.81 | 1e-06 | 1e-05 |
| GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.88% (4/68) | 5.74 | 1e-06 | 1.2e-05 |
| GO:0045901 | positive regulation of translational elongation | 4.41% (3/68) | 7.17 | 1e-06 | 1.4e-05 |
| GO:0001651 | dense fibrillar component | 4.41% (3/68) | 7.17 | 1e-06 | 1.4e-05 |
| GO:0000469 | cleavage involved in rRNA processing | 7.35% (5/68) | 4.77 | 1e-06 | 1.4e-05 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 32.35% (22/68) | 1.6 | 1e-06 | 1.4e-05 |
| GO:0030218 | erythrocyte differentiation | 5.88% (4/68) | 5.68 | 1e-06 | 1.4e-05 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 38.24% (26/68) | 1.39 | 1e-06 | 1.6e-05 |
| GO:0070034 | telomerase RNA binding | 4.41% (3/68) | 7.05 | 1e-06 | 1.7e-05 |
| GO:0045471 | response to ethanol | 7.35% (5/68) | 4.71 | 1e-06 | 1.7e-05 |
| GO:0010468 | regulation of gene expression | 35.29% (24/68) | 1.46 | 2e-06 | 2.1e-05 |
| GO:0030515 | snoRNA binding | 5.88% (4/68) | 5.49 | 2e-06 | 2.3e-05 |
| GO:0008284 | positive regulation of cell population proliferation | 11.76% (8/68) | 3.23 | 2e-06 | 2.5e-05 |
| GO:0065007 | biological regulation | 64.71% (44/68) | 0.82 | 3e-06 | 2.9e-05 |
| GO:0031386 | protein tag | 4.41% (3/68) | 6.75 | 3e-06 | 3.1e-05 |
| GO:0008201 | heparin binding | 4.41% (3/68) | 6.75 | 3e-06 | 3.1e-05 |
| GO:0043021 | ribonucleoprotein complex binding | 8.82% (6/68) | 3.9 | 3e-06 | 3.6e-05 |
| GO:0031323 | regulation of cellular metabolic process | 39.71% (27/68) | 1.28 | 3e-06 | 3.8e-05 |
| GO:0090501 | RNA phosphodiester bond hydrolysis | 8.82% (6/68) | 3.87 | 4e-06 | 4e-05 |
| GO:0065003 | protein-containing complex assembly | 17.65% (12/68) | 2.34 | 4e-06 | 4e-05 |
| GO:0016020 | membrane | 54.41% (37/68) | 0.95 | 5e-06 | 5.4e-05 |
| GO:0050789 | regulation of biological process | 60.29% (41/68) | 0.85 | 6e-06 | 6.1e-05 |
| GO:0005844 | polysome | 5.88% (4/68) | 5.08 | 6e-06 | 6.8e-05 |
| GO:0031090 | organelle membrane | 33.82% (23/68) | 1.4 | 7e-06 | 7.4e-05 |
| GO:0019222 | regulation of metabolic process | 42.65% (29/68) | 1.15 | 8e-06 | 8.6e-05 |
| GO:0010604 | positive regulation of macromolecule metabolic process | 26.47% (18/68) | 1.66 | 8e-06 | 8.9e-05 |
| GO:0021554 | optic nerve development | 2.94% (2/68) | 8.58 | 9e-06 | 9.1e-05 |
| GO:0000454 | snoRNA guided rRNA pseudouridine synthesis | 2.94% (2/68) | 8.58 | 9e-06 | 9.1e-05 |
| GO:0090661 | box H/ACA telomerase RNP complex | 2.94% (2/68) | 8.58 | 9e-06 | 9.1e-05 |
| GO:0099577 | regulation of translation at presynapse, modulating synaptic transmission | 2.94% (2/68) | 8.58 | 9e-06 | 9.1e-05 |
| GO:0140244 | regulation of translation at presynapse | 2.94% (2/68) | 8.58 | 9e-06 | 9.1e-05 |
| GO:0000049 | tRNA binding | 5.88% (4/68) | 4.96 | 9e-06 | 9.2e-05 |
| GO:0006725 | cellular aromatic compound metabolic process | 36.76% (25/68) | 1.29 | 9e-06 | 9.4e-05 |
| GO:0009965 | leaf morphogenesis | 8.82% (6/68) | 3.61 | 1e-05 | 0.000103 |
| GO:0034198 | cellular response to amino acid starvation | 4.41% (3/68) | 6.11 | 1.1e-05 | 0.000112 |
| GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.88% (4/68) | 4.83 | 1.3e-05 | 0.000124 |
| GO:0031326 | regulation of cellular biosynthetic process | 32.35% (22/68) | 1.38 | 1.4e-05 | 0.000135 |
| GO:0055105 | ubiquitin-protein transferase inhibitor activity | 4.41% (3/68) | 6.0 | 1.4e-05 | 0.000139 |
| GO:1990948 | ubiquitin ligase inhibitor activity | 4.41% (3/68) | 6.0 | 1.4e-05 | 0.000139 |
| GO:0006414 | translational elongation | 5.88% (4/68) | 4.77 | 1.5e-05 | 0.00014 |
| GO:0032502 | developmental process | 51.47% (35/68) | 0.93 | 1.6e-05 | 0.000152 |
| GO:0000478 | endonucleolytic cleavage involved in rRNA processing | 5.88% (4/68) | 4.74 | 1.6e-05 | 0.000152 |
| GO:0031290 | retinal ganglion cell axon guidance | 2.94% (2/68) | 8.17 | 1.8e-05 | 0.000167 |
| GO:0006448 | regulation of translational elongation | 4.41% (3/68) | 5.89 | 1.8e-05 | 0.000167 |
| GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 4.41% (3/68) | 5.89 | 1.8e-05 | 0.000167 |
| GO:0005539 | glycosaminoglycan binding | 4.41% (3/68) | 5.85 | 2e-05 | 0.000184 |
| GO:0009889 | regulation of biosynthetic process | 32.35% (22/68) | 1.34 | 2.3e-05 | 0.000212 |
| GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 5.88% (4/68) | 4.6 | 2.4e-05 | 0.000217 |
| GO:0048522 | positive regulation of cellular process | 33.82% (23/68) | 1.29 | 2.4e-05 | 0.000219 |
| GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 8.82% (6/68) | 3.3 | 3.4e-05 | 0.000306 |
| GO:1901796 | regulation of signal transduction by p53 class mediator | 5.88% (4/68) | 4.47 | 3.4e-05 | 0.000307 |
| GO:0030490 | maturation of SSU-rRNA | 5.88% (4/68) | 4.45 | 3.5e-05 | 0.000315 |
| GO:0009790 | embryo development | 16.18% (11/68) | 2.1 | 4.5e-05 | 0.000389 |
| GO:0031429 | box H/ACA snoRNP complex | 2.94% (2/68) | 7.58 | 4.5e-05 | 0.000391 |
| GO:0034513 | box H/ACA snoRNA binding | 2.94% (2/68) | 7.58 | 4.5e-05 | 0.000391 |
| GO:0072588 | box H/ACA RNP complex | 2.94% (2/68) | 7.58 | 4.5e-05 | 0.000391 |
| GO:0099171 | presynaptic modulation of chemical synaptic transmission | 2.94% (2/68) | 7.58 | 4.5e-05 | 0.000391 |
| GO:1901360 | organic cyclic compound metabolic process | 36.76% (25/68) | 1.15 | 4.5e-05 | 0.000394 |
| GO:0071493 | cellular response to UV-B | 4.41% (3/68) | 5.39 | 5.1e-05 | 0.000442 |
| GO:0009893 | positive regulation of metabolic process | 26.47% (18/68) | 1.46 | 5.6e-05 | 0.00048 |
| GO:0055106 | ubiquitin-protein transferase regulator activity | 4.41% (3/68) | 5.33 | 5.9e-05 | 0.000504 |
| GO:0030099 | myeloid cell differentiation | 5.88% (4/68) | 4.25 | 6.1e-05 | 0.000518 |
| GO:0001934 | positive regulation of protein phosphorylation | 7.35% (5/68) | 3.59 | 6.2e-05 | 0.000521 |
| GO:0000171 | ribonuclease MRP activity | 2.94% (2/68) | 7.36 | 6.2e-05 | 0.000523 |
| GO:0031120 | snRNA pseudouridine synthesis | 2.94% (2/68) | 7.36 | 6.2e-05 | 0.000523 |
| GO:0045860 | positive regulation of protein kinase activity | 5.88% (4/68) | 4.22 | 6.5e-05 | 0.000537 |
| GO:0006913 | nucleocytoplasmic transport | 7.35% (5/68) | 3.58 | 6.5e-05 | 0.000539 |
| GO:0051169 | nuclear transport | 7.35% (5/68) | 3.56 | 6.8e-05 | 0.000555 |
| GO:0036464 | cytoplasmic ribonucleoprotein granule | 8.82% (6/68) | 3.11 | 7e-05 | 0.000572 |
| GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic | 5.88% (4/68) | 4.18 | 7.4e-05 | 0.000599 |
| GO:0044877 | protein-containing complex binding | 13.24% (9/68) | 2.32 | 7.6e-05 | 0.000613 |
| GO:0035770 | ribonucleoprotein granule | 8.82% (6/68) | 3.09 | 7.6e-05 | 0.000614 |
| GO:0000154 | rRNA modification | 4.41% (3/68) | 5.17 | 8.2e-05 | 0.000659 |
| GO:1905267 | endonucleolytic cleavage involved in tRNA processing | 2.94% (2/68) | 7.17 | 8.3e-05 | 0.000661 |
| GO:0042327 | positive regulation of phosphorylation | 7.35% (5/68) | 3.43 | 0.000103 | 0.000818 |
| GO:0021545 | cranial nerve development | 2.94% (2/68) | 7.0 | 0.000107 | 0.00084 |
| GO:0033674 | positive regulation of kinase activity | 5.88% (4/68) | 4.04 | 0.000107 | 0.000843 |
| GO:0071840 | cellular component organization or biogenesis | 36.76% (25/68) | 1.08 | 0.000108 | 0.000846 |
| GO:1902533 | positive regulation of intracellular signal transduction | 8.82% (6/68) | 2.98 | 0.000116 | 0.000904 |
| GO:0045182 | translation regulator activity | 7.35% (5/68) | 3.35 | 0.000133 | 0.001021 |
| GO:0006407 | rRNA export from nucleus | 2.94% (2/68) | 6.85 | 0.000133 | 0.001023 |
| GO:0034101 | erythrocyte homeostasis | 2.94% (2/68) | 6.85 | 0.000133 | 0.001023 |
| GO:0051168 | nuclear export | 5.88% (4/68) | 3.95 | 0.000137 | 0.00104 |
| GO:0051029 | rRNA transport | 2.94% (2/68) | 6.71 | 0.000162 | 0.001213 |
| GO:0017085 | response to insecticide | 2.94% (2/68) | 6.71 | 0.000162 | 0.001213 |
| GO:0099547 | regulation of translation at synapse, modulating synaptic transmission | 2.94% (2/68) | 6.71 | 0.000162 | 0.001213 |
| GO:0140243 | regulation of translation at synapse | 2.94% (2/68) | 6.71 | 0.000162 | 0.001213 |
| GO:0031640 | killing of cells of another organism | 4.41% (3/68) | 4.82 | 0.000169 | 0.001253 |
| GO:0051338 | regulation of transferase activity | 8.82% (6/68) | 2.86 | 0.000183 | 0.001352 |
| GO:0051173 | positive regulation of nitrogen compound metabolic process | 22.06% (15/68) | 1.5 | 0.00019 | 0.001398 |
| GO:0021675 | nerve development | 2.94% (2/68) | 6.58 | 0.000195 | 0.00142 |
| GO:0031118 | rRNA pseudouridine synthesis | 2.94% (2/68) | 6.58 | 0.000195 | 0.00142 |
| GO:0048027 | mRNA 5'-UTR binding | 4.41% (3/68) | 4.73 | 0.000204 | 0.001478 |
| GO:0044085 | cellular component biogenesis | 10.29% (7/68) | 2.53 | 0.000214 | 0.001545 |
| GO:0042127 | regulation of cell population proliferation | 11.76% (8/68) | 2.3 | 0.00022 | 0.001579 |
| GO:0072717 | cellular response to actinomycin D | 2.94% (2/68) | 6.47 | 0.00023 | 0.001638 |
| GO:0002262 | myeloid cell homeostasis | 2.94% (2/68) | 6.47 | 0.00023 | 0.001638 |
| GO:0010562 | positive regulation of phosphorus metabolic process | 7.35% (5/68) | 3.17 | 0.00024 | 0.001696 |
| GO:0045937 | positive regulation of phosphate metabolic process | 7.35% (5/68) | 3.17 | 0.00024 | 0.001696 |
| GO:0072716 | response to actinomycin D | 2.94% (2/68) | 6.36 | 0.000268 | 0.001866 |
| GO:0000172 | ribonuclease MRP complex | 2.94% (2/68) | 6.36 | 0.000268 | 0.001866 |
| GO:0040031 | snRNA modification | 2.94% (2/68) | 6.36 | 0.000268 | 0.001866 |
| GO:0048518 | positive regulation of biological process | 35.29% (24/68) | 1.03 | 0.000273 | 0.001895 |
| GO:0001906 | cell killing | 4.41% (3/68) | 4.58 | 0.000276 | 0.001903 |
| GO:0097064 | ncRNA export from nucleus | 2.94% (2/68) | 6.26 | 0.000309 | 0.002113 |
| GO:0046632 | alpha-beta T cell differentiation | 2.94% (2/68) | 6.26 | 0.000309 | 0.002113 |
| GO:0010557 | positive regulation of macromolecule biosynthetic process | 17.65% (12/68) | 1.67 | 0.000322 | 0.002195 |
| GO:0031325 | positive regulation of cellular metabolic process | 22.06% (15/68) | 1.41 | 0.000373 | 0.002532 |
| GO:0046677 | response to antibiotic | 4.41% (3/68) | 4.43 | 0.000376 | 0.00254 |
| GO:0031428 | box C/D RNP complex | 2.94% (2/68) | 6.08 | 0.000399 | 0.002672 |
| GO:0046631 | alpha-beta T cell activation | 2.94% (2/68) | 6.08 | 0.000399 | 0.002672 |
| GO:0071005 | U2-type precatalytic spliceosome | 4.41% (3/68) | 4.39 | 0.000404 | 0.002696 |
| GO:1903321 | negative regulation of protein modification by small protein conjugation or removal | 4.41% (3/68) | 4.31 | 0.000481 | 0.003193 |
| GO:0060041 | retina development in camera-type eye | 2.94% (2/68) | 5.85 | 0.000555 | 0.003672 |
| GO:0071011 | precatalytic spliceosome | 4.41% (3/68) | 4.2 | 0.000603 | 0.00397 |
| GO:0071417 | cellular response to organonitrogen compound | 7.35% (5/68) | 2.86 | 0.000643 | 0.004215 |
| GO:1990932 | 5.8S rRNA binding | 2.94% (2/68) | 5.71 | 0.000674 | 0.004381 |
| GO:0010458 | exit from mitosis | 2.94% (2/68) | 5.71 | 0.000674 | 0.004381 |
| GO:0031399 | regulation of protein modification process | 11.76% (8/68) | 2.05 | 0.000687 | 0.00445 |
| GO:0006405 | RNA export from nucleus | 4.41% (3/68) | 4.12 | 0.000701 | 0.004521 |
| GO:0001223 | transcription coactivator binding | 2.94% (2/68) | 5.64 | 0.000737 | 0.004733 |
| GO:0097525 | spliceosomal snRNP complex | 4.41% (3/68) | 4.09 | 0.000743 | 0.004752 |
| GO:0051347 | positive regulation of transferase activity | 5.88% (4/68) | 3.27 | 0.000817 | 0.005204 |
| GO:0042254 | ribosome biogenesis | 4.41% (3/68) | 4.04 | 0.000831 | 0.005276 |
| GO:0030666 | endocytic vesicle membrane | 4.41% (3/68) | 4.02 | 0.000855 | 0.005401 |
| GO:0001522 | pseudouridine synthesis | 2.94% (2/68) | 5.52 | 0.000872 | 0.005487 |
| GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway | 2.94% (2/68) | 5.47 | 0.000943 | 0.005914 |
| GO:0031328 | positive regulation of cellular biosynthetic process | 17.65% (12/68) | 1.5 | 0.000961 | 0.005999 |
| GO:0031625 | ubiquitin protein ligase binding | 7.35% (5/68) | 2.72 | 0.000978 | 0.006058 |
| GO:0030532 | small nuclear ribonucleoprotein complex | 4.41% (3/68) | 3.96 | 0.000977 | 0.006073 |
| GO:0051444 | negative regulation of ubiquitin-protein transferase activity | 2.94% (2/68) | 5.41 | 0.001018 | 0.00623 |
| GO:1904667 | negative regulation of ubiquitin protein ligase activity | 2.94% (2/68) | 5.41 | 0.001018 | 0.00623 |
| GO:0007004 | telomere maintenance via telomerase | 2.94% (2/68) | 5.41 | 0.001018 | 0.00623 |
| GO:0120114 | Sm-like protein family complex | 4.41% (3/68) | 3.92 | 0.001055 | 0.006406 |
| GO:0048872 | homeostasis of number of cells | 4.41% (3/68) | 3.92 | 0.001055 | 0.006406 |
| GO:0022607 | cellular component assembly | 17.65% (12/68) | 1.48 | 0.001079 | 0.006529 |
| GO:0070181 | small ribosomal subunit rRNA binding | 2.94% (2/68) | 5.36 | 0.001095 | 0.006598 |
| GO:0019899 | enzyme binding | 16.18% (11/68) | 1.56 | 0.001117 | 0.006632 |
| GO:0071897 | DNA biosynthetic process | 4.41% (3/68) | 3.89 | 0.001109 | 0.006632 |
| GO:0002376 | immune system process | 14.71% (10/68) | 1.67 | 0.001107 | 0.006647 |
| GO:0009891 | positive regulation of biosynthetic process | 17.65% (12/68) | 1.47 | 0.001117 | 0.006656 |
| GO:0000822 | inositol hexakisphosphate binding | 2.94% (2/68) | 5.31 | 0.001174 | 0.006867 |
| GO:0071320 | cellular response to cAMP | 2.94% (2/68) | 5.31 | 0.001174 | 0.006867 |
| GO:1902555 | endoribonuclease complex | 2.94% (2/68) | 5.31 | 0.001174 | 0.006867 |
| GO:0006278 | RNA-templated DNA biosynthetic process | 2.94% (2/68) | 5.31 | 0.001174 | 0.006867 |
| GO:0044389 | ubiquitin-like protein ligase binding | 7.35% (5/68) | 2.66 | 0.001193 | 0.006952 |
| GO:1905348 | endonuclease complex | 2.94% (2/68) | 5.26 | 0.001257 | 0.007267 |
| GO:0010833 | telomere maintenance via telomere lengthening | 2.94% (2/68) | 5.26 | 0.001257 | 0.007267 |
| GO:1902806 | regulation of cell cycle G1/S phase transition | 4.41% (3/68) | 3.82 | 0.001282 | 0.007386 |
| GO:1901699 | cellular response to nitrogen compound | 7.35% (5/68) | 2.6 | 0.001416 | 0.008126 |
| GO:0046649 | lymphocyte activation | 4.41% (3/68) | 3.73 | 0.001538 | 0.008796 |
| GO:0032986 | protein-DNA complex disassembly | 2.94% (2/68) | 5.08 | 0.001614 | 0.009194 |
| GO:0045859 | regulation of protein kinase activity | 5.88% (4/68) | 3.0 | 0.001623 | 0.009213 |
| GO:0034644 | cellular response to UV | 4.41% (3/68) | 3.69 | 0.001678 | 0.009488 |
| GO:0001932 | regulation of protein phosphorylation | 7.35% (5/68) | 2.54 | 0.001712 | 0.00965 |
| GO:0072589 | box H/ACA scaRNP complex | 1.47% (1/68) | 9.17 | 0.00174 | 0.009768 |
| GO:0043085 | positive regulation of catalytic activity | 7.35% (5/68) | 2.52 | 0.001821 | 0.010187 |
| GO:0032526 | response to retinoic acid | 2.94% (2/68) | 4.96 | 0.001909 | 0.010645 |
| GO:0071236 | cellular response to antibiotic | 2.94% (2/68) | 4.92 | 0.002013 | 0.011105 |
| GO:2001235 | positive regulation of apoptotic signaling pathway | 2.94% (2/68) | 4.92 | 0.002013 | 0.011105 |
| GO:0005689 | U12-type spliceosomal complex | 2.94% (2/68) | 4.92 | 0.002013 | 0.011105 |
| GO:0042273 | ribosomal large subunit biogenesis | 2.94% (2/68) | 4.88 | 0.00212 | 0.011651 |
| GO:0043549 | regulation of kinase activity | 5.88% (4/68) | 2.87 | 0.002221 | 0.012166 |
| GO:0048856 | anatomical structure development | 35.29% (24/68) | 0.82 | 0.002277 | 0.01243 |
| GO:0098793 | presynapse | 4.41% (3/68) | 3.52 | 0.002313 | 0.012579 |
| GO:0051896 | regulation of protein kinase B signaling | 2.94% (2/68) | 4.81 | 0.00234 | 0.012685 |
| GO:0045321 | leukocyte activation | 4.41% (3/68) | 3.51 | 0.002357 | 0.012729 |
| GO:0005684 | U2-type spliceosomal complex | 4.41% (3/68) | 3.48 | 0.002538 | 0.01366 |
| GO:0009967 | positive regulation of signal transduction | 10.29% (7/68) | 1.91 | 0.002552 | 0.013691 |
| GO:0005686 | U2 snRNP | 2.94% (2/68) | 4.74 | 0.002572 | 0.013747 |
| GO:1901681 | sulfur compound binding | 4.41% (3/68) | 3.45 | 0.002679 | 0.014272 |
| GO:0032147 | activation of protein kinase activity | 2.94% (2/68) | 4.68 | 0.002813 | 0.014835 |
| GO:0071480 | cellular response to gamma radiation | 2.94% (2/68) | 4.68 | 0.002813 | 0.014835 |
| GO:0030217 | T cell differentiation | 2.94% (2/68) | 4.68 | 0.002813 | 0.014835 |
| GO:1902808 | positive regulation of cell cycle G1/S phase transition | 2.94% (2/68) | 4.64 | 0.002938 | 0.015439 |
| GO:0001775 | cell activation | 4.41% (3/68) | 3.39 | 0.002976 | 0.015588 |
| GO:0004540 | ribonuclease activity | 4.41% (3/68) | 3.39 | 0.003027 | 0.015804 |
| GO:1904666 | regulation of ubiquitin protein ligase activity | 2.94% (2/68) | 4.61 | 0.003065 | 0.015946 |
| GO:0044093 | positive regulation of molecular function | 8.82% (6/68) | 2.07 | 0.003076 | 0.01595 |
| GO:1905392 | plant organ morphogenesis | 8.82% (6/68) | 2.07 | 0.003113 | 0.016088 |
| GO:0042325 | regulation of phosphorylation | 7.35% (5/68) | 2.33 | 0.003222 | 0.016598 |
| GO:0015030 | Cajal body | 2.94% (2/68) | 4.55 | 0.003327 | 0.017081 |
| GO:0090204 | protein localization to nuclear pore | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:1902164 | positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:1902167 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:1904803 | regulation of translation involved in cellular response to UV | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0008746 | NAD(P)+ transhydrogenase activity | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0016652 | oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0051434 | BH3 domain binding | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0070513 | death domain binding | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:1990630 | IRE1-RACK1-PP2A complex | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0002227 | innate immune response in mucosa | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0019731 | antibacterial humoral response | 1.47% (1/68) | 8.17 | 0.003476 | 0.017119 |
| GO:0031401 | positive regulation of protein modification process | 7.35% (5/68) | 2.3 | 0.003545 | 0.0174 |
| GO:0032040 | small-subunit processome | 2.94% (2/68) | 4.49 | 0.003598 | 0.017609 |
| GO:0001221 | transcription coregulator binding | 2.94% (2/68) | 4.44 | 0.00388 | 0.018871 |
| GO:0046540 | U4/U6 x U5 tri-snRNP complex | 2.94% (2/68) | 4.44 | 0.00388 | 0.018871 |
| GO:0023056 | positive regulation of signaling | 10.29% (7/68) | 1.8 | 0.003908 | 0.018945 |
| GO:0051248 | negative regulation of protein metabolic process | 8.82% (6/68) | 1.99 | 0.003967 | 0.019171 |
| GO:0097526 | spliceosomal tri-snRNP complex | 2.94% (2/68) | 4.41 | 0.004025 | 0.019393 |
| GO:0010647 | positive regulation of cell communication | 10.29% (7/68) | 1.78 | 0.004172 | 0.019979 |
| GO:0007411 | axon guidance | 2.94% (2/68) | 4.39 | 0.004172 | 0.020041 |
| GO:0140513 | nuclear protein-containing complex | 11.76% (8/68) | 1.63 | 0.004205 | 0.020073 |
| GO:0050657 | nucleic acid transport | 4.41% (3/68) | 3.21 | 0.004298 | 0.020393 |
| GO:0050658 | RNA transport | 4.41% (3/68) | 3.21 | 0.004298 | 0.020393 |
| GO:0051236 | establishment of RNA localization | 4.41% (3/68) | 3.2 | 0.004362 | 0.020635 |
| GO:0004857 | enzyme inhibitor activity | 5.88% (4/68) | 2.6 | 0.004389 | 0.020699 |
| GO:0045292 | mRNA cis splicing, via spliceosome | 2.94% (2/68) | 4.31 | 0.004629 | 0.021764 |
| GO:0031400 | negative regulation of protein modification process | 5.88% (4/68) | 2.56 | 0.004766 | 0.022341 |
| GO:0016073 | snRNA metabolic process | 2.94% (2/68) | 4.28 | 0.004786 | 0.022368 |
| GO:1990259 | histone-glutamine methyltransferase activity | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0046554 | malate dehydrogenase (NADP+) activity | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0060267 | positive regulation of respiratory burst | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0003360 | brainstem development | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0002251 | organ or tissue specific immune response | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0002385 | mucosal immune response | 1.47% (1/68) | 7.58 | 0.00521 | 0.02378 |
| GO:0097485 | neuron projection guidance | 2.94% (2/68) | 4.24 | 0.005107 | 0.023799 |
| GO:0051438 | regulation of ubiquitin-protein transferase activity | 2.94% (2/68) | 4.21 | 0.005272 | 0.023922 |
| GO:0042110 | T cell activation | 2.94% (2/68) | 4.21 | 0.005272 | 0.023922 |
| GO:0098978 | glutamatergic synapse | 4.41% (3/68) | 3.09 | 0.005398 | 0.024423 |
| GO:0007275 | multicellular organism development | 16.18% (11/68) | 1.26 | 0.005594 | 0.02524 |
| GO:0006413 | translational initiation | 2.94% (2/68) | 4.12 | 0.005953 | 0.026781 |
| GO:0071310 | cellular response to organic substance | 11.76% (8/68) | 1.53 | 0.00618 | 0.02772 |
| GO:0071479 | cellular response to ionizing radiation | 2.94% (2/68) | 4.06 | 0.006489 | 0.029025 |
| GO:0036009 | protein-glutamine N-methyltransferase activity | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0030292 | protein tyrosine kinase inhibitor activity | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0042169 | SH2 domain binding | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0060263 | regulation of respiratory burst | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1903207 | regulation of hydrogen peroxide-induced neuron death | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1903208 | negative regulation of hydrogen peroxide-induced neuron death | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1990447 | U2 snRNP binding | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0043097 | pyrimidine nucleoside salvage | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0030622 | U4atac snRNA binding | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1904841 | TORC2 complex binding | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0043051 | regulation of pharyngeal pumping | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1901193 | regulation of formation of translation preinitiation complex | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1901194 | negative regulation of formation of translation preinitiation complex | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:1904689 | negative regulation of cytoplasmic translational initiation | 1.47% (1/68) | 7.17 | 0.006941 | 0.029765 |
| GO:0050790 | regulation of catalytic activity | 10.29% (7/68) | 1.64 | 0.007151 | 0.030583 |
| GO:0000122 | negative regulation of transcription by RNA polymerase II | 5.88% (4/68) | 2.38 | 0.007491 | 0.031947 |
| GO:0031397 | negative regulation of protein ubiquitination | 2.94% (2/68) | 3.92 | 0.007822 | 0.03327 |
| GO:2000059 | negative regulation of ubiquitin-dependent protein catabolic process | 2.94% (2/68) | 3.9 | 0.008022 | 0.033934 |
| GO:0001650 | fibrillar center | 2.94% (2/68) | 3.9 | 0.008022 | 0.033934 |
| GO:0050829 | defense response to Gram-negative bacterium | 4.41% (3/68) | 2.87 | 0.008161 | 0.03443 |
| GO:0048478 | replication fork protection | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:1904046 | negative regulation of vascular endothelial growth factor production | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0000451 | rRNA 2'-O-methylation | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0000494 | box C/D RNA 3'-end processing | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0001652 | granular component | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0033967 | box C/D RNA metabolic process | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0034963 | box C/D RNA processing | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0051400 | BH domain binding | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0051901 | positive regulation of mitochondrial depolarization | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0071208 | histone pre-mRNA DCP binding | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0004845 | uracil phosphoribosyltransferase activity | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0044211 | CTP salvage | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0005690 | U4atac snRNP | 1.47% (1/68) | 6.85 | 0.008669 | 0.034875 |
| GO:0009507 | chloroplast | 11.76% (8/68) | 1.45 | 0.008826 | 0.035419 |
| GO:0010243 | response to organonitrogen compound | 11.76% (8/68) | 1.44 | 0.008916 | 0.035597 |
| GO:1902531 | regulation of intracellular signal transduction | 8.82% (6/68) | 1.76 | 0.008474 | 0.035654 |
| GO:0099080 | supramolecular complex | 8.82% (6/68) | 1.75 | 0.008908 | 0.035655 |
| GO:0051591 | response to cAMP | 2.94% (2/68) | 3.81 | 0.009054 | 0.035871 |
| GO:0045861 | negative regulation of proteolysis | 4.41% (3/68) | 2.82 | 0.009034 | 0.035885 |
| GO:1903320 | regulation of protein modification by small protein conjugation or removal | 4.41% (3/68) | 2.82 | 0.009034 | 0.035885 |
| GO:0071495 | cellular response to endogenous stimulus | 8.82% (6/68) | 1.76 | 0.008591 | 0.036049 |
| GO:0050821 | protein stabilization | 4.41% (3/68) | 2.84 | 0.00864 | 0.036061 |
| GO:0010332 | response to gamma radiation | 2.94% (2/68) | 3.85 | 0.008634 | 0.036134 |
| GO:2000058 | regulation of ubiquitin-dependent protein catabolic process | 4.41% (3/68) | 2.79 | 0.009543 | 0.037711 |
| GO:0019220 | regulation of phosphate metabolic process | 7.35% (5/68) | 1.95 | 0.009693 | 0.038207 |
| GO:1903051 | negative regulation of proteolysis involved in protein catabolic process | 2.94% (2/68) | 3.74 | 0.00992 | 0.039006 |
| GO:0000445 | THO complex part of transcription export complex | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0048254 | snoRNA localization | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0005078 | MAP-kinase scaffold activity | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0010470 | regulation of gastrulation | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0051898 | negative regulation of protein kinase B signaling | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0051900 | regulation of mitochondrial depolarization | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:2000543 | positive regulation of gastrulation | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0045495 | pole plasm | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0044206 | UMP salvage | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0060744 | mammary gland branching involved in thelarche | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0060425 | lung morphogenesis | 1.47% (1/68) | 6.58 | 0.010393 | 0.039283 |
| GO:0030098 | lymphocyte differentiation | 2.94% (2/68) | 3.69 | 0.010593 | 0.039941 |
| GO:0051174 | regulation of phosphorus metabolic process | 7.35% (5/68) | 1.92 | 0.010335 | 0.040533 |
| GO:0043178 | alcohol binding | 2.94% (2/68) | 3.71 | 0.010366 | 0.040557 |
| GO:0051117 | ATPase binding | 2.94% (2/68) | 3.68 | 0.010822 | 0.040705 |
| GO:0016043 | cellular component organization | 27.94% (19/68) | 0.77 | 0.010953 | 0.0411 |
| GO:0005640 | nuclear outer membrane | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0044613 | nuclear pore central transport channel | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0017126 | nucleologenesis | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1990258 | histone glutamine methylation | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0016505 | peptidase activator activity involved in apoptotic process | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1904181 | positive regulation of membrane depolarization | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0071204 | histone pre-mRNA 3'end processing complex | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1904044 | response to aldosterone | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0034512 | box C/D RNA binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0001552 | ovarian follicle atresia | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0001846 | opsonin binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0001848 | complement binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0001850 | complement component C3a binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0001851 | complement component C3b binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0023035 | CD40 signaling pathway | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0030449 | regulation of complement activation | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0031871 | proteinase activated receptor binding | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0032740 | positive regulation of interleukin-17 production | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0035632 | mitochondrial prohibitin complex | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0045917 | positive regulation of complement activation | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0050847 | progesterone receptor signaling pathway | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0072538 | T-helper 17 type immune response | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1990051 | activation of protein kinase C activity | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0048246 | macrophage chemotaxis | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1904688 | regulation of cytoplasmic translational initiation | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:1905517 | macrophage migration | 1.47% (1/68) | 6.36 | 0.012115 | 0.042499 |
| GO:0031329 | regulation of cellular catabolic process | 7.35% (5/68) | 1.85 | 0.012497 | 0.043643 |
| GO:0048467 | gynoecium development | 2.94% (2/68) | 3.57 | 0.012483 | 0.04369 |
| GO:0071345 | cellular response to cytokine stimulus | 4.41% (3/68) | 2.68 | 0.01174 | 0.043948 |
| GO:0050896 | response to stimulus | 52.94% (36/68) | 0.45 | 0.012047 | 0.044988 |
| GO:0017022 | myosin binding | 2.94% (2/68) | 3.54 | 0.012977 | 0.045216 |
| GO:0016363 | nuclear matrix | 2.94% (2/68) | 3.52 | 0.013227 | 0.045985 |
| GO:0010574 | regulation of vascular endothelial growth factor production | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0018364 | peptidyl-glutamine methylation | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0080093 | regulation of photorespiration | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:1903204 | negative regulation of oxidative stress-induced neuron death | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0004849 | uridine kinase activity | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0010138 | pyrimidine ribonucleotide salvage | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0032262 | pyrimidine nucleotide salvage | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0007202 | activation of phospholipase C activity | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0010863 | positive regulation of phospholipase C activity | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0030421 | defecation | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0060749 | mammary gland alveolus development | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0098891 | extrinsic component of presynaptic active zone membrane | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0140374 | antiviral innate immune response | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 1.47% (1/68) | 6.17 | 0.013834 | 0.046242 |
| GO:0071478 | cellular response to radiation | 5.88% (4/68) | 2.13 | 0.013409 | 0.046514 |
| GO:1903131 | mononuclear cell differentiation | 2.94% (2/68) | 3.51 | 0.013479 | 0.046654 |
| GO:0004521 | endoribonuclease activity | 2.94% (2/68) | 3.49 | 0.013733 | 0.047429 |
| GO:0043022 | ribosome binding | 2.94% (2/68) | 3.47 | 0.014248 | 0.047525 |
| GO:2000045 | regulation of G1/S transition of mitotic cell cycle | 2.94% (2/68) | 3.44 | 0.014771 | 0.049165 |